Procurement Summary
Country : USA
Summary : Fda-21-Rfq-1238675 Obp Idiq for Pharmaceuticals
Deadline : 13 May 2021
Other Information
Notice Type : Tender
TOT Ref.No.: 52540781
Document Ref. No. : Req-1238675
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
FDA-21-RFQ-1238675 OBP IDIQ for Pharmaceuticals
Active Contract Opportunity
Notice ID : Req-1238675
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : FOOD AND DRUG ADMINISTRATION
Office : FDA Office of Acquisitions and Grants Services
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 23, 2021 11:58 am EDT
Original Date Offers Due: May 13, 2021 03:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: May 28, 2021
Initiative: None
Classification
Original Set Aside: Total Small Business Set-Aside (FAR 19.5)
Product Service Code: Q999 - MEDICAL- OTHER
NAICS Code: 424210 - Drugs and Druggists' Sundries Merchant Wholesalers
Place of Performance: Silver Spring, MD 20993 USA
Description
The Contractor(s) shall fulfill orders from the FDA on an as-needed basis for biologics and other drugs currently sold in the US market. The FDA will request both brand name and biosimilar products, which may include, but are not limited to, monoclonal antibodies, bispecific antibodies, enzymes, cytokines, growth factors, fusion proteins, antibody-drug conjugates, peptide therapeutics and drug-device combination products, related molecules, small molecules, complex products, and contrast agents. A listin...
Documents
Tender Notice